» Articles » PMID: 15653820

Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium Tuberculosis

Overview
Specialty Microbiology
Date 2005 Jan 18
PMID 15653820
Citations 240
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacterium tuberculosis is known to synthesize alpha-, methoxy-, and keto-mycolic acids. We propose a detailed pathway to the biosynthesis of all mycolic acids in M. tuberculosis. Fatty acid synthetase I provides C(20)-S-coenzyme A to the fatty acid synthetase II system (FAS-IIA). Modules of FAS-IIA and FAS-IIB introduce cis unsaturation at two locations on a growing meroacid chain to yield three different forms of cis,cis-diunsaturated fatty acids (intermediates to alpha-, methoxy-, and keto-meroacids). These are methylated, and the mature meroacids and carboxylated C(26)-S-acyl carrier protein enter into the final Claisen-type condensation with polyketide synthase-13 (Pks13) to yield mycolyl-S-Pks13. We list candidate genes in the genome encoding the proposed dehydrase and isomerase in the FAS-IIA and FAS-IIB modules. We propose that the processing of mycolic acids begins by transfer of mycolic acids from mycolyl-S-Pks13 to d-mannopyranosyl-1-phosphoheptaprenol to yield 6-O-mycolyl-beta-d-mannopyranosyl-1-phosphoheptaprenol and then to trehalose 6-phosphate to yield phosphorylated trehalose monomycolate (TMM-P). Phosphatase releases the phosphate group to yield TMM, which is immediately transported outside the cell by the ABC transporter. Antigen 85 then catalyzes the transfer of a mycolyl group from TMM to the cell wall arabinogalactan and to other TMMs to produce arabinogalactan-mycolate and trehalose dimycolate, respectively. We list candidate genes in the genome that encode the proposed mycolyltransferases I and II, phosphatase, and ABC transporter. The enzymes within this total pathway are targets for new drug discovery.

Citing Articles

New pyrazole-based derivatives targeting MmpL3 transporter in Mycobacterium tuberculosis: design, synthesis, biological evaluation and molecular docking studies.

Maddipatla S, Agnivesh P, Bakchi B, Nanduri S, Kalia N, Yaddanapudi V Mol Divers. 2025; .

PMID: 40085403 DOI: 10.1007/s11030-025-11152-3.


Targeting the Heart of Mycobacterium: Advances in Anti-Tubercular Agents Disrupting Cell Wall Biosynthesis.

Diab A, Dickerson H, Al Musaimi O Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861133 PMC: 11768153. DOI: 10.3390/ph18010070.


The CRISPR-dCas9 interference system suppresses inhA gene expression in Mycobacterium smegmatis.

Singpanomchai N, Ratthawongjirakul P Sci Rep. 2024; 14(1):26116.

PMID: 39478003 PMC: 11525817. DOI: 10.1038/s41598-024-77442-2.


Unveiling Insights into the Whole Genome Sequencing of spp. Isolated from Siamese Fighting Fish ().

Dinh-Hung N, Mwamburi S, Dong H, Rodkhum C, Meemetta W, Linh N Animals (Basel). 2024; 14(19).

PMID: 39409782 PMC: 11476334. DOI: 10.3390/ani14192833.


Trehalose catalytic shift is an intrinsic factor in Mycobacterium tuberculosis that enhances phenotypic heterogeneity and multidrug resistance.

Eoh H, Lee J, Swanson D, Lee S, Dihardjo S, Lee G Res Sq. 2024; .

PMID: 39315249 PMC: 11419184. DOI: 10.21203/rs.3.rs-4999164/v1.


References
1.
Takayama K, Qureshi N . Isolation and characterization of the monounsaturated long chain fatty acids of Mycobacterium tuberculosis. Lipids. 1978; 13(9):575-9. DOI: 10.1007/BF02535818. View

2.
Jackson M, Raynaud C, Laneelle M, Guilhot C, Laurent-Winter C, Ensergueix D . Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol. 1999; 31(5):1573-87. DOI: 10.1046/j.1365-2958.1999.01310.x. View

3.
Bateman A, Birney E, Durbin R, Eddy S, Howe K, Sonnhammer E . The Pfam protein families database. Nucleic Acids Res. 1999; 28(1):263-6. PMC: 102420. DOI: 10.1093/nar/28.1.263. View

4.
Armitige L, Jagannath C, Wanger A, Norris S . Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect Immun. 2000; 68(2):767-78. PMC: 97204. DOI: 10.1128/IAI.68.2.767-778.2000. View

5.
Ronning D, Klabunde T, Besra G, Vissa V, Belisle J, Sacchettini J . Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat Struct Biol. 2000; 7(2):141-6. DOI: 10.1038/72413. View